New Breakthrough in International Medical Problems: NYO3 Helps China and Norway Jointly Explore a New Future of Krill Oil Medical Nutrition
Following the three major chronic diseases, Alzheimer’s disease, a type of neurodegenerative condition that primarily affects the elderly, has become one of the most formidable medical challenges. With the aging society intensifying, the global number of patients is expected to exceed 150 million by 2050. Regarded as the “Mount Everest” of the medical community, the treatment and improvement of Alzheimer’s disease represent a notoriously difficult subject in the international medical field, and efforts to address it persistently continue.
Among international experts in the field of human aging and age-susceptible neurodegeneration mechanisms, Professor Evandro Fei Fang, the Chief Medical and Scientific Advisor of NYO3, holds a prestigious position. In his research, he particularly focuses on the role of krill oil in “inhibiting Alzheimer’s disease in the elderly,” preventing “neuron loss,” and suppressing “cell senescence in normal aging.” As a recognition of his contributions, he received a national research award personally presented by King Harald V of Norway this year. During the recently concluded NYO3 Global Brand Ceremony, Professor Evandro Fei Fang shared these research findings.
A significant breakthrough in Alzheimer’s disease created a sensation in the medical community and was personally awarded by the King of Norway
The internationally recognized medical journal “Aging” recently published the latest research findings on Alzheimer’s disease. A research team from Oslo University Hospital and Akershus University Hospital, led by Professors Hilde Nilsen and Evandro Fei Fang, utilized nematodes to simulate human cells and study whether krill oil can slow down the aging process. The study revealed that nematodes receiving krill oil experienced fewer nerve cell losses in their brains as they aged. Krill oil can promote healthy aging by influencing several processes that drive aging, significantly improving the survival of dopaminergic neurons in aging nematodes and demonstrating a significant anti-aging effect.
Therefore, as a dietary nutritional supplement, krill oil has a positive impact on slowing down aging and preventing Alzheimer’s disease during the aging process. NYO3 krill oil is rich in nutrients such as OMEGA-3 (DHA/EPA), choline, and astaxanthin. It also positively affects regulating cholesterol levels, protecting cardiovascular systems, maintaining joint health, preserving eyesight, and enhancing immunity.
In light of recent breakthroughs in drug development for Alzheimer’s disease and anti-aging, Prof. Evandro Fei Fang was honored with the “Alzheimer’s Disease Research Award of the Norwegian Public Health Association,” personally presented by King Harald V of Norway in 2023. This award recognizes his outstanding contributions to Alzheimer’s disease prevention research and nutritional innovation. As a professor at the University of Oslo (UiO) and Akershus University Hospital in Norway, he has also received the Butler-Williams Scholar Award for Aging (USA), the 2020 Natural Science Young Scientist Science Award (Norway), and other accolades.
Focusing on krill oil, Norway and China collaboratively promote academic exploration of international dietary supplements
At the recently concluded NYO3 Brand Ceremony, numerous experts and scholars shared the latest academic advancements in krill oil related to heart and brain health. Notably, clinical studies have demonstrated that krill oil can significantly decrease blood triglyceride levels. After patients took krill oil for 26 weeks, the blood triglyceride levels reduced by 33.5% compared to the baseline. This study was published on January 6, 2022, in the internationally renowned journal JAMA Network Open. Concurrently, Prof. Evandro Fei Fang, Chief Medical and Scientific Advisor of NYO3, shared the positive effects of krill oil in “protecting neurons from the effects of age-related degeneration” and anti-aging. He provided guidance for international research and development in the fight against Alzheimer’s disease, indicating new directions for medicines and dietary supplements.
At this year’s 2nd Bauhinia Metabolomics International Conference at Tsinghua University, Prof. Evandro Fei Fang delivered a speech on related academic topics. He shared insights that Antarctic krill oil operates at the cellular level to promote healthy aging and enhance public health through dietary supplements, emphasizing the far-reaching significance of the upgrade. Norway and China collaborate on cutting-edge scientific research to support the innovative research and development of medical nutrition, such as Antarctic krill oil, and the enhancement of public health dietary supplements. This partnership lays the foundation for the innovative application of international dietary supplements in medical nutrition.
Released the world’s top new krill oil product, leading the Norwegian dietary supplement quality to rise again
Condensing three years of scientific research results by NYO3 Chief Medical and Scientific Advisor, Prof. Evandro Fei Fang, and the University of Oslo (UiO) laboratory, NYO3 unveiled its high-end new product, NYO3 Gold Amundsen Krill Oil, for the first time at the NYO3 Global Brand Ceremony.
As a krill oil product that currently surpasses international standards, NYO3 Gold Amundsen Krill Oil integrates cell-level medical care concepts and patented purification technology. It utilizes NYO3’s strategic partner and the world’s leading krill oil raw material supplier in the Fortune 500, Aker BioMarine. Their high-end SUPERBAboost pure Antarctic krill oil boasts an industry-high content of 750mg/tablet and a measured 58% “ceiling-level” marine phospholipid content. The small molecules target cardiovascular and cerebrovascular cells, safely regulating blood lipids and protecting heart and brain health. The new custom-made gold gift box, featuring Nordic aesthetic elements, blends Amundsen’s courageous exploration concept with product quality upgrades. It is specially designed to be the premier choice for elite healthcare, opening a new chapter in cell-level targeted care.
Scientific research and innovation have become the cornerstone of the health industry’s sustainable development, continually infusing the brand with vitality. Commencing with the innovative scientific research strength of Prof. Evandro Fei Fang’s R&D team and a strategic partnership with Aker BioMarine, NYO3 remains committed to the brand concept of “originating from Norwegian natural purity.” Through natural ingredient formulas and cutting-edge scientific research with patented technology, NYO3 focuses on creating natural, scientifically proven, and efficient medical nutritional supplements. The brand aims to delve into medical research in the realms of cell-level maintenance, health, and longevity. By promoting innovative applications of medical nutritional dietary supplements, NYO3 seeks to lead the international dietary supplement industry’s innovative development, continuously opening new chapters in human health and well-being.
